May 2, 2026 - 19:47

Berkshire Hathaway reported a strong jump in first-quarter earnings on Saturday, with operating profits climbing across its major businesses. Speaking at the company's annual shareholder meeting in Omaha, CEO Greg Abel emphasized a growing focus on technology and artificial intelligence as key drivers for the conglomerate's future growth.
Abel, who succeeded Warren Buffett as chief executive, pointed to significant investments in automation and data analytics at Geico, the insurance giant, and at BNSF Railway. He said these tools are helping cut costs, improve customer service, and streamline logistics. "Technology is not just an add-on for us. It is a core opportunity across our entire portfolio," Abel told the crowd.
Berkshire's energy division also saw a boost, with Abel noting that AI-driven grid management and renewable energy projects are opening new revenue streams. The company's cash pile remained massive, nearing $190 billion, but Abel signaled a willingness to deploy capital into tech-focused acquisitions if the right deal emerges.
The meeting drew thousands of shareholders, many of whom were hearing Abel take the lead role for the first time. While Buffett remained on stage for part of the event, Abel's confident tone on innovation marked a shift for the traditionally cautious firm. "We are not chasing hype," Abel said. "But we are absolutely chasing efficiency."
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...